Multiple Doses of DM199 in Patients With Chronic Kidney Disease (REDUX)
Trial details
- Registry ID
- NCT04123613
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Multiple Doses of DM199 in Patients With Chronic Kidney Disease (REDUX)NCT04123613 | DMAC | Phase 2 | Completed | 2022-03-16Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |